Researchers have uncovered a shared brain cell breakdown mechanism behind Alzheimer’s and Parkinson’s diseases, revealing how ...
Neurotransmitter levels in the brain can indicate brain health and neurodegenerative diseases like Alzheimer's. However, the protective blood-brain barrier (BBB) makes delivering fluorescent sensors ...
Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...
Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment
AI modeling, Alzheimer’s tissue analyses, and preclinical porosome studies have identified a fundamental cause of Alzheimer’s disease, paving the way for innovative treatment pathways aimed at ...
A new study from Western University is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk ...
News-Medical.Net on MSN
Researchers reveal common synaptic pathway behind Parkinson’s and Alzheimer’s diseases
Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...
In a magical scene towards the end of 2007 film Ratatouille), notoriously harsh food critic Anton Ego is instantly ...
Health Beet on MSN
Listening to This May Significantly Reduce Dementia Risk, Study Finds
Engaging with music could offer more than just enjoyment — it may also help protect the brain against cognitive decline. A ...
A variety of Alzheimer’s medications can help manage different symptoms and improve quality of life as the disease progresses. Alzheimer’s medications help manage symptoms by improving memory, ...
Neurotransmitter levels in the brain can indicate brain health and neurodegenerative diseases like Alzheimer’s. However, the protective blood-brain barrier (BBB) makes delivering fluorescent sensors ...
Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment
Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced its latest development in identifying the secretory dysfunction responsible for Alzheimer’s Disease along with advancements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results